Quest AD-Detect® Phosphorylated tau217 (p-tau217), Plasma details

Compare labs

Switch to see each lab’s details

Quest AD-Detect® Phosphorylated tau217 (p-tau217), Plasma

Labcorp

Broadest draw-site network nationwide.

This test is coming soon at Labcorp.

Quest AD-Detect® Phosphorylated tau217 (p-tau217), Plasma

Quest Diagnostics

Same-day appointments in most metros.

Sample type: Plasma
Avg. sample processing time: 5 Business days
Require fasting: No

BiomarkersQuest Diagnostics biomarkers

pTau217

$320.49

Description

Current research indicates that plasma p-tau, including p-tau 217, is concordant with amyloid status defined by either CSF biomarker testing or PET scan analysis, and is able to differentiate between AD and non-AD neurodegenerative diseases and to predict progression to AD. Blood-based biomarkers, such as plasma p-tau, could potentially be used as inclusion criteria or to evaluate target engagement and treatment efficacy, and could further advance the development of disease-modifying treatments in the field of AD and related disorders. This assay is designed specifically for the quantitative measurement of tau phosphorylated at threonine 217 (p-tau 217) in human plasma.

Included biomarkers

Biomarkers

pTau217

Preparation

Labcorp

This test is coming soon at Labcorp.

Quest Diagnostics

Stop biotin consumption at least 72 hours prior to collection of a sample.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

ConsultationsConsultation

Not sure how to read your results? We can help.

Schedule a consultation with a Hormunity specialist. We’ll walk through every marker, interpret what it means for you, and map out the next steps for your care.

Book a specialist